摘要

<正>Immune cell-based therapies, such as chimeric antigen receptor T cells (CAR T) therapies and dendritic cell (DC) vaccines are producing tremendous opportunities for treating previously incurable diseases. Cellular immunotherapy holds some unique advantages.Adoptively transferred immune cells can persist in the body and offers a long-term protection to patients. In addition,